PanGenetics B.V.
Year founded
-
Country of origin
Netherlands
HQ country
Netherlands
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
PanGenetics B.V. founded in 1995, develops monoclonal antibodies for the treatment of immune mediated diseases, cancer, and pain. The company develops a portfolio of antibody drugs through in-licensing model.